Search research articles
Contact Us
Filters
Showing results (21-30 of 142) with videos related to
Page
of 15
Sort By:
Inflammatory Bowel Diseases
|
September 26, 2008
What is the optimal maintenance treatment for ulcerative colitis?
Russell D Cohen
Current Opinion in Gastroenterology
|
December 5, 2024
Editorial
Russell D Cohen
Digestive Diseases and Sciences
|
April 8, 2023
Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis
Tenzin Choden, Russell D Cohen
Drug Design, Development and Therapy
|
March 31, 2011
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine
Lilliana Oliveira, Russell D Cohen
Gastroenterology Clinics of North America
|
November 30, 2006
Economics of the use of biologics in the treatment of inflammatory bowel disease
Russell D Cohen, Tojo Thomas
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies
Tojo Thomas, Russell D Cohen
Current Treatment Options in Gastroenterology
|
August 12, 2006
Management of refractory ulcerative colitis
Sunana Sohi, Russell D Cohen
Therapeutics and Clinical Risk Management
|
May 14, 2008
Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
Prashant Kedia, Russell D Cohen
Gastroenterology & Hepatology
|
April 19, 2021
A Comprehensive Review of Topical Therapies for Distal Ulcerative Colitis
Russell D Cohen, Roni Weisshof
Current Gastroenterology Reports
|
April 25, 2019
Maneuvering Clinical Pathways for Crohn's Disease
Thomas X Lu, Russell D Cohen
Page
of 15
Search research articles
Search
Showing results (21-30 of 142) with videos related to
Sort By:
Page
of 15
Inflammatory Bowel Diseases
|
September 26, 2008
What is the optimal maintenance treatment for ulcerative colitis?
Russell D Cohen
Current Opinion in Gastroenterology
|
December 5, 2024
Editorial
Russell D Cohen
Digestive Diseases and Sciences
|
April 8, 2023
Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis
Tenzin Choden, Russell D Cohen
Drug Design, Development and Therapy
|
March 31, 2011
Maintaining remission in ulcerative colitis--role of once daily extended-release mesalamine
Lilliana Oliveira, Russell D Cohen
Gastroenterology Clinics of North America
|
November 30, 2006
Economics of the use of biologics in the treatment of inflammatory bowel disease
Russell D Cohen, Tojo Thomas
Expert Review of Gastroenterology & Hepatology
|
December 17, 2008
Pharmacoeconomic considerations for inflammatory bowel disease in the era of biological therapies
Tojo Thomas, Russell D Cohen
Current Treatment Options in Gastroenterology
|
August 12, 2006
Management of refractory ulcerative colitis
Sunana Sohi, Russell D Cohen
Therapeutics and Clinical Risk Management
|
May 14, 2008
Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
Prashant Kedia, Russell D Cohen
Gastroenterology & Hepatology
|
April 19, 2021
A Comprehensive Review of Topical Therapies for Distal Ulcerative Colitis
Russell D Cohen, Roni Weisshof
Current Gastroenterology Reports
|
April 25, 2019
Maneuvering Clinical Pathways for Crohn's Disease
Thomas X Lu, Russell D Cohen
Page
of 15